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Editorial
Acute promyelocytic leukemia (APL), once a rapidly
fatal disease, has become most curable of all leukemias,
thanks to the two Chinese wonder drugs, all-trans reti-
noid acid and arsenic trioxide (AT). PML-RXARa fusion
protein is the hallmark and driving force of APL. In the
April 9th issue of the journal, Science, Zhang et al. pro-
vided new and convincing evidence on how AT, an
ancient poisonous medicine, plays the tricks on the
oncoprotein, PML-RARa, and sheds lights on how a
poisonous kiss leads to the sweet fruit [1].
A comprehensive approach and an epic story of
science
Zhang et al. have indeed done a tremendous amount of
work in this study. Several cell lines and transfectants
were used and/or established, including HEK 293T,
NB4, and HeLa cells, to name a few. Numerous mutants
of PML as well as EGFP-fusion proteins were generated
to pinpoint the kissing spot of AT. To be even more
convincing, two additional organic arsenicals, PAPAO,
and ReAsH, were also employed. With collaborations
from the leading institutions of biotechnology and phy-
sics in China, MALDI-TOF mass spectrometry, EXAFS,
XANES spectroscopy, and circular dichroism were
orchestrated marvelously into the study. As the study
evolves, it reads like an epic story of science.
Solid evidences-with no stones left unturned
The scientific team has provided strong and convincing
evidence step by step and proved to the world that AT
poisons the PML-RARa protein by kissing the cysteine
residues in the zinc fingers within the RBCC domain of
PML. They first demonstrated that AT binds to PML-,
not the RARa - portion of the fusion oncoprotein.
Using EGFP-fusion mutants of PML protein, they
showed colocalization of arsenicals with various PML
mutants, and pinpointed that AT binds to the RING
domain of PML. With the help of NMR and a variety of
technologies of physics, arsenic-sulfur bonds were pro-
ven to form through the conserved cysteine residues,
and the number of arsenic atoms bound to the PML
peptides were also defined. The biological consequences
of arsenic binding to PML, the enhanced interaction of
PML with UBC9 leading to increased degradation of
PML-RARa, were further explored both in vitro and in
vivo. In the end, a working model was proposed to
explain how the poisonous kiss controls the fate of
PML-RARa and leads to the sweet cure of APL.
Masterful collaborations between leading Chinese
institutions and international laboratories
As soon as you read the study, it is obvious that the suc-
cess of this remarkable work proves again the importance
of collaborations between major leading institutions in
China as well as with international laboratories. With the
vast experience and knowledge from decades long of
scientific endeavors in the world-renowned laboratories of
Drs. Zhu Chen and Sai-Juan Chen, the collaborations
between leading Chinese institutions and international
laboratories were skillfully mastered to utilize the neces-
sary tools and technology and generate the convincing and
authoritative scientific data. This sets up a historical exam-
ple in China for collaborations among leading laboratories
and institutions to embark on scientific frontiers and
achieve international leadership quickly and effectively.
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